2019: A Banner Year for Tuberculosis Research

J Infect Dis. 2020 Nov 9;222(11):1768-1771. doi: 10.1093/infdis/jiaa051.

Abstract

This article outlines the significant scientific progress reported in 2019 that has led to the development of new drugs and therapeutic regimens, vaccine candidates, and diagnostics for the prevention and treatment of tuberculosis. In 2020, it will be important to build on this momentum and continue to advance basic and clinical research to develop improved tools and interventions, simultaneously optimizing their implementation in national control programs. To successfully achieve the goal to end tuberculosis within a generation, a concerted, collective, and collaborative effort is required, involving government, academia, industry and civil society at all levels.

Keywords: tuberculosis prevention and treatment.

Publication types

  • Research Support, N.I.H., Extramural

MeSH terms

  • Animals
  • Antitubercular Agents / therapeutic use
  • Humans
  • Mycobacterium tuberculosis
  • Tuberculosis / diagnosis
  • Tuberculosis / immunology
  • Tuberculosis / prevention & control*
  • Tuberculosis / therapy*
  • Tuberculosis Vaccines

Substances

  • Antitubercular Agents
  • Tuberculosis Vaccines